vancomycin has been researched along with tacrolimus in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Hooker, M | 1 |
| Cleveland, KO; Lacasse, A | 1 |
| Dorsch, MP; Early, CR; Hanigan, SM; Park, JM; Pogue, KT | 1 |
| Akalya, K; Chua, HR; Da, Y; Lau, T; Lim, HN; Low, S; Murali, T; Ong, L; Tan, CS; Teo, BW; Vathsala, A | 1 |
| de Geus, HRH; Endeman, H; Hoek, RAS; Hunfeld, N; Smeets, T | 1 |
3 review(s) available for vancomycin and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clostridium difficile.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Beclomethasone; Biopsy; Budesonide; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infection Control; Male; Metronidazole; Middle Aged; Oncology Nursing; Primary Myelofibrosis; Risk Factors; Tacrolimus; Vancomycin | 2007 |
Trichosporon mucoides fungemia in a liver transplant recipient: case report and review.
Topics: Antifungal Agents; Enterococcus faecium; Fatal Outcome; Fungemia; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycoses; Peritonitis; Postoperative Complications; Tacrolimus; Triazoles; Trichosporon; Vancomycin; Vancomycin Resistance | 2009 |
1 trial(s) available for vancomycin and tacrolimus
| Article | Year |
|---|---|
Serial Quantification of Urinary Protein Biomarkers to Predict Drug-induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Adult; Aged; Aminoglycosides; Amphotericin B; beta 2-Microglobulin; Biomarkers; Calcineurin Inhibitors; Chemokine CCL2; Clusterin; Cyclosporine; Cystatin C; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Male; Middle Aged; Tacrolimus; Vancomycin | 2019 |
8 other study(ies) available for vancomycin and tacrolimus
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile.
Topics: Adult; Aged; Anti-Bacterial Agents; Clinical Decision-Making; Clostridioides difficile; Clostridium Infections; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Immunosuppressive Agents; Male; Metronidazole; Middle Aged; Organ Transplantation; Retrospective Studies; Tacrolimus; Treatment Outcome; Vancomycin | 2016 |
The Seraph®-100 Microbind Affinity Blood Filter Does Not Affect Vancomycin, Tacrolimus, and Mycophenolic Acid Plasma Concentrations.
Topics: Aged; Anti-Bacterial Agents; Female; Filtration; Hemoperfusion; Humans; Immunosuppressive Agents; Mycophenolic Acid; Tacrolimus; Vancomycin | 2021 |